Aclaris Therapeutics, Inc.
ACRS
$2.83
-$0.05-1.74%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.90% | -5.23% | -7.29% | -11.06% | 14.97% |
| Total Receivables | 2,312.37% | -22.40% | -97.20% | 2,500.00% | 5.54% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 30.25% | -6.19% | -19.37% | -31.40% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.46% | -4.22% | -13.63% | -4.82% | 12.49% |
|
|
|||||
| Total Current Assets | -3.46% | -4.22% | -13.63% | -4.82% | 12.49% |
| Net Property, Plant & Equipment | -5.76% | -5.81% | -5.22% | -6.26% | -6.57% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.25% | -4.50% | 98.21% | -7.82% | -7.25% |
| Total Assets | -7.20% | -4.52% | -10.09% | 20.80% | 13.24% |
|
|
|||||
| Total Accounts Payable | 4.43% | 38.45% | 35.48% | -38.79% | 5.41% |
| Total Accrued Expenses | 20.21% | 5.90% | -39.75% | 142.28% | -7.85% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.50% | 3.41% | 3.53% | 3.44% | 3.56% |
| Total Finance Division Other Current Liabilities | -20.47% | 25.73% | -46.44% | 149.27% | 65.60% |
| Total Other Current Liabilities | -20.47% | 25.73% | -46.44% | 149.27% | 65.60% |
| Total Current Liabilities | -4.50% | 24.75% | -31.91% | 67.92% | 19.98% |
|
|
|||||
| Total Current Liabilities | -4.50% | 24.75% | -31.91% | 67.92% | 19.98% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -7.56% | -6.80% | -6.19% | -5.70% | -5.15% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -2.18% | -5.93% | -1.71% | -0.39% | 238.93% |
| Total Liabilities | -3.44% | 6.26% | -16.59% | 23.98% | 91.72% |
|
|
|||||
| Common Stock & APIC | 0.27% | 0.29% | 0.31% | 13.06% | 0.32% |
| Retained Earnings | -1.57% | -1.68% | -1.67% | -11.97% | -0.95% |
| Treasury Stock & Other | 23.86% | 11.06% | 347.42% | -77.28% | 192.22% |
| Total Common Equity | -8.83% | -8.56% | -7.39% | 19.52% | -2.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -8.83% | -8.56% | -7.39% | 19.52% | -2.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -8.83% | -8.56% | -7.39% | 19.52% | -2.74% |
|
|
|||||